Company intelligence / Profile preview

Ayana Bio

Boston, Massachusetts, United Statesayanabio.com ↗

Ownership: Private
Employees: ~50
Development stage: Preclinical

Overview

Ayana Bio has developed proprietary plant cell culture technologies to produce high-quality botanical and fungal bioactives at scale. The company supplies these ingredients for use in food & beverage, supplements, cosmetics and related industries. It does not have pharmaceutical clinical trial results but has received an NIH grant to explore neuroprotective benefits of its products.

Therapeutic areas: Other
Modalities: Plant cell-derived bioactives (botanical and fungal)Nutraceuticals/functional ingredients (not traditional therapeutics like small molecules or mAbs)
Industry: Non-Drug Biotech

Partnerships

Ginkgo Bioworks (synthetic biology platform partnership)Wooree Green Science/Wooree Bio – joint development agreement for saffron/bioactives in Korea

Beyond the preview

Go deeper on Ayana Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ayana Bio.

Explore the full profile